Frailty and Inflammatory Bowel Disease: A Nationwide Assessment.
作者信息
Kilani Yassine, Alsakarneh Saqr, Aldiabat Mohammad, Ferreira Mariana Nunes, Gonzalez Mosquera Daniel Alejandro, Jaber Fouad, Farraye Francis A, Hashash Jana G
机构信息
Department of Medicine, Lincoln Medical Center - Weill Cornell Medical College, New York, New York.
Department of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
出版信息
Gastro Hep Adv. 2024 Jul 14;3(7):1001-1004. doi: 10.1016/j.gastha.2024.07.003. eCollection 2024.
Abstract
摘要
相似文献
1
Frailty and Inflammatory Bowel Disease: A Nationwide Assessment.衰弱与炎症性肠病：一项全国性评估。
Gastro Hep Adv. 2024 Jul 14;3(7):1001-1004. doi: 10.1016/j.gastha.2024.07.003. eCollection 2024.
2
Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study.老年发病炎症性肠病的脆弱风险和治疗策略。一项基于挪威全国人群的登记研究。
Dig Liver Dis. 2024 Sep;56(9):1503-1510. doi: 10.1016/j.dld.2024.02.002. Epub 2024 Mar 2.
3
Association between inflammatory bowel disease and frailty: a two-sample Mendelian randomization study.炎症性肠病与衰弱之间的关联：一项两样本孟德尔随机化研究。
Aging Clin Exp Res. 2024 Feb 6;36(1):21. doi: 10.1007/s40520-023-02688-1.
4
Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence.衰弱与炎症性肠病：当前证据的范围综述
J Clin Med. 2023 Jan 9;12(2):533. doi: 10.3390/jcm12020533.
5
Prevalence and Implications of Frailty in Older Adults With Incident Inflammatory Bowel Diseases: A Nationwide Cohort Study.新发炎症性肠病老年患者中衰弱的患病率及其影响：一项全国性队列研究
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2358-2365.e11. doi: 10.1016/j.cgh.2022.01.001. Epub 2022 Jan 6.
6
Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases.虚弱与炎症性肠病住院患者的死亡率和再入院率独立相关。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2054-2063.e14. doi: 10.1016/j.cgh.2020.08.010. Epub 2020 Aug 12.
7
Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence.炎症性肠病中的肌肉减少症和衰弱：新出现的概念与证据
JGH Open. 2024 Jan 27;8(1):e13033. doi: 10.1002/jgh3.13033. eCollection 2024 Jan.
8
Frailty in inflammatory bowel disease: analysis of the National Inpatient Sample 2015-2019.炎症性肠病患者的虚弱状况：2015-2019 年国家住院患者样本分析。
Colorectal Dis. 2024 May;26(5):958-967. doi: 10.1111/codi.16967. Epub 2024 Apr 4.
9
Frailty in inflammatory bowel diseases: an emerging concept.炎症性肠病中的衰弱：一个新兴概念。
Therap Adv Gastroenterol. 2021 Sep 24;14:17562848211025474. doi: 10.1177/17562848211025474. eCollection 2021.
10
The Prevalence and Factors That Impact Frailty in Inflammatory Bowel Disease Patients Hospitalized in a Tertiary Hospital in China.中国一家三级医院住院炎症性肠病患者衰弱的流行情况及其影响因素。
Dig Dis. 2023;41(3):396-404. doi: 10.1159/000528459. Epub 2022 Dec 1.
本文引用的文献
1
Absolute and Relative Risks of Kidney and Urological Complications in Patients With Inflammatory Bowel Disease.炎症性肠病患者发生肾脏和泌尿系统并发症的绝对风险和相对风险
Am J Gastroenterol. 2024 Jan 1;119(1):138-146. doi: 10.14309/ajg.0000000000002473. Epub 2023 Aug 10.
2
Impact of infection in patients admitted with ulcerative colitis.感染对溃疡性结肠炎住院患者的影响。
Scand J Gastroenterol. 2023 Mar;58(3):232-239. doi: 10.1080/00365521.2022.2121175. Epub 2022 Sep 8.
3
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.炎症性肠病的肠外表现：当前概念、治疗和对疾病管理的影响。
Gastroenterology. 2021 Oct;161(4):1118-1132. doi: 10.1053/j.gastro.2021.07.042. Epub 2021 Aug 3.
4
Aging and IBD: A New Challenge for Clinicians and Researchers.衰老与炎症性肠病：临床医生和研究人员面临的新挑战。
Inflamm Bowel Dis. 2022 Jan 5;28(1):126-132. doi: 10.1093/ibd/izab039.
5
Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.炎症性肠病住院患者衰弱症的患病率不断增加及其与再入院和死亡的关系。
Dig Dis Sci. 2021 Dec;66(12):4178-4190. doi: 10.1007/s10620-020-06746-w. Epub 2021 Jan 1.
6
Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases.虚弱与炎症性肠病住院患者的死亡率和再入院率独立相关。
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2054-2063.e14. doi: 10.1016/j.cgh.2020.08.010. Epub 2020 Aug 12.
7
Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.预处理衰弱与炎症性肠病患者免疫抑制后感染风险增加独立相关。
Gastroenterology. 2020 Jun;158(8):2104-2111.e2. doi: 10.1053/j.gastro.2020.02.032. Epub 2020 Feb 25.
8
Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study.开发和验证一个专注于急性护理环境中老年人的医院衰弱风险评分，使用电子医院记录：一项观察性研究。
Lancet. 2018 May 5;391(10132):1775-1782. doi: 10.1016/S0140-6736(18)30668-8. Epub 2018 Apr 26.
9
Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases.炎症性肠病患者发生急性心肌梗死和心力衰竭的风险增加。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1607-1615.e1. doi: 10.1016/j.cgh.2018.04.031. Epub 2018 Apr 24.
10
Management of inflammatory bowel disease with infection.炎症性肠病合并感染的管理
World J Gastroenterol. 2017 Jul 21;23(27):4986-5003. doi: 10.3748/wjg.v23.i27.4986.
Zotero 插件